Agile Therapeutics, Inc. (AGRX)

Analysts 5
Positive
100%
Median target $10 (314% upside)


    • 01/27/17
      RBC Capital
      outperform
      $8
      "We hosted meetings with AGRX with focus on approval path for lead contraceptive patch product..."
      View details
    • 01/06/17
      FBR Capital Markets
      outperform
      $10
      "We note that the highest PI approved by the FDA to date is 3.19 and the highest upper bound of..."
      View details
    • 01/04/17
      Cantor Fitzgerald
      overweight
      $7
      "We believe that AGRX has run a robust trial reflective of the real world population and that..."
      View details
    • 01/04/17
      Janney Montgomery Scott
      buy
      $15
    • 08/09/16
      Noble Financial
      buy
      $15
    • 11/10/15
      William Blair
      outperform
      $18
    • 12/30/14
      Sterne Agee
      buy
    • 100% positive
      $10 Median

    Best rated in Drugs - Generic last 7 days

    more

    Users who viewed AGRX also viewed

    more

    Best rated stocks last 7 days

    more

    Most rated stocks last 72 hrs

    more